Potential impact of tuberculosis vaccines in China, South Africa, and India-Reference-Cited by-同舟云学术

Potential impact of tuberculosis vaccines in China, South Africa, and India

Published:2020-10-07 Issue:564 Volume:12 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Harris Rebecca C.¹^ORCID,Sumner Tom¹^ORCID,Knight Gwenan M.¹^ORCID,Zhang Hui²^ORCID,White Richard G.¹^ORCID

Affiliation:

1. TB Modelling Group, TB Centre and Centre for the Mathematical Modelling of Infectious Diseases, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, Keppel Street, London WC1E 7HT, UK.

2. Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Abstract

Tuberculosis vaccines should aim to protect infected populations against disease, but other vaccine types may be of use in high-transmission settings.

Funder

Bill and Melinda Gates Foundation

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference125 articles.

1. World Health Organization (2018). “Global Tuberculosis Report 2018.” Retrieved 9th October 2018 from http://apps.who.int/iris/bitstream/handle/10665/274453/9789241565646-eng.pdf?ua=1.

2. Stop TB Partnership (2015). “The Global Plan to End TB 2016-2020. The Paradigm Shift.”. Retrieved 2nd November 2018 from http://www.stoptb.org/assets/documents/global/plan/GlobalPlanToEndTB_TheParadigmShift_2016-2020_StopTBPartnership.pdf.

3. Research and development of new tuberculosis vaccines: a review

4. Final Analysis of a Trial of M72/AS01E Vaccine to Prevent Tuberculosis

5. Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modelling the health and economic impacts of M72/AS01E vaccination and BCG-revaccination: Estimates for South Africa;Vaccine;2024-02

2. Mapping the Existing Body of Knowledge on New and Repurposed TB Vaccine Implementation: A Scoping Review;2024-01-18

3. Tuberculosis and the Effectiveness of the Revised National Tuberculosis Control Program (RNTCP) to Control Tuberculosis: A Narrative Review;Cureus;2023-12-31

4. Modelling the health and economic impacts of M72/AS01_Evaccination and BCG-revaccination: estimates for South Africa;2023-10-05

5. Scientific advances and the end of tuberculosis: a report from the Lancet Commission on Tuberculosis;The Lancet;2023-10